Compare GV & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GV | GCTK |
|---|---|---|
| Founded | 2013 | 2001 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1M | 1.3M |
| IPO Year | 2021 | 2011 |
| Metric | GV | GCTK |
|---|---|---|
| Price | $0.23 | $0.77 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 44.3M | 2.4M |
| Earning Date | 08-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 31.22 |
| Revenue | N/A | ★ $589,462.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.03 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.18 | $0.09 |
| 52 Week High | $4.18 | $15.90 |
| Indicator | GV | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 34.42 | 39.14 |
| Support Level | $0.18 | $0.62 |
| Resistance Level | $0.55 | $1.00 |
| Average True Range (ATR) | 0.07 | 0.11 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 6.32 | 40.37 |
Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.